Itemoids

You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

2025September › 11

Merck

10 months ago

Merck's pneumococcal vaccine showed strong immune responses in children and teens at higher risk of serious illness in a late-stage study, the drugmaker said.

Warning follows news of US drugmaker Merck’s decision to scrap planned £1bn London research centre

Sir John Bell, a prominent scientist who brought business and government together during the Covid-19…

The firm, known as MSD in Europe, said there has been a lack of investment in life sciences.

page 1 of 1